Tacedinaline, also known as Acetyldinaline, has been in phase III clinical trials by Pfizer for the treatment of advanced non-small cell lung cancer. Reference standards of Tacedinaline API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below.
Tacedinaline
Catalogue No.:PA 20 2950000
CAS :
Molecular Formula : C15H15N3O2
Molecular Weight : 269.3
I accept terms and conditions
Message sent successfully!! We will get back to you shortly ....
